Foresite Capital Management II’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-50,000	Closed	-$719K	–	13
2017 Q2	$719K	Buy	+50,000	New	+$719K	0.33%	9